Yan-Dong Su1, Ru Ma2, Yu-Bin Fu1

  • 1Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.

PubMed
概括

使用患者衍生瘤样细胞群 (PTC) 药物敏感性测试进行的个性化化疗显著改善了恶性周周围膜间皮质瘤 (MPM) 患者的生存率. 最优的治疗方案包括氧沙,凝和阿帕蒂尼布.